A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells. (Q51735874)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Maria Teresa Di Martino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Pierfrancesco Tassone

object named as

Pierfrancesco Tassone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Pierosandro Tagliaferri

object named as

Pierosandro Tagliaferri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Marzia Leotta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Lavinia Biamonte

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Emanuela Leone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Maria Rita Pitari

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Nicola Amodio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

1 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular Physiology

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

2106-2116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms

18 March 2020

cites work

1 reference

Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas

21 January 2018

1 reference

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1

21 January 2018

1 reference

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma.

21 January 2018

1 reference

miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells

21 January 2018

1 reference

Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma

21 January 2018

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

miR-29b: a new demethylator in multiple myeloma

21 January 2018

1 reference

MicroRNAs: novel regulators during the immune response.

21 January 2018

1 reference

Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.

21 January 2018

1 reference

Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma

21 January 2018

1 reference

The p53 pathway and apoptosis

21 January 2018

1 reference

A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells.

21 January 2018

1 reference

MicroRNA as a new player in the cell cycle

21 January 2018

1 reference

MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival

21 January 2018

1 reference

Clinical significance of TP53 mutation in myeloma

21 January 2018

1 reference

Small RNAs: regulators and guardians of the genome

21 January 2018

1 reference

Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data

21 January 2018

1 reference

miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.

21 January 2018

1 reference

The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells.

21 January 2018

1 reference

A critical role for the NFkB pathway in multiple myeloma

21 January 2018

1 reference

Mechanisms of microRNA deregulation in human cancer

21 January 2018

1 reference

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

21 January 2018

1 reference

In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma

21 January 2018

1 reference

Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma

21 January 2018

1 reference

Stress-induced p53 runs a direct mitochondrial death program: its role in physiologic and pathophysiologic stress responses in vivo

21 January 2018

1 reference

The tumor suppressor p53: cancer and aging

21 January 2018

1 reference

MicroRNA profiling in human medulloblastoma.

21 January 2018

1 reference

MYD88-independent growth and survival effects of Sp1 transactivation in Waldenstrom macroglobulinemia.

21 January 2018

1 reference

Targeting microRNAs in cancer: rationale, strategies and challenges

21 January 2018

1 reference

Genetic screen identifies microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells.

21 January 2018

1 reference

The p53 tumor suppressor participates in multiple cell cycle checkpoints

21 January 2018

1 reference

Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.

21 January 2018

1 reference

Suppressing miRNA-15a/-16 expression by interleukin-6 enhances drug-resistance in myeloma cells

21 January 2018

1 reference

p53 mutations in human cancers

21 January 2018

1 reference

MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells

21 January 2018

1 reference

MicroRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells

21 January 2018

1 reference

MicroRNAs miR-125a and miR-125b constitutively activate the NF-κB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)

21 January 2018

1 reference

Strategies for profiling microRNA expression

21 January 2018

1 reference

Insights into cellular microRNAs and human immunodeficiency virus type 1 (HIV-1).

21 January 2018

1 reference

Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth

21 January 2018

1 reference

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

The emerging functions of the p53-miRNA network in stem cell biology

21 January 2018

1 reference

Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma.

21 January 2018

1 reference

Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia.

21 January 2018

1 reference

Identification of the transcriptional promoters in the proximal regions of human microRNA genes

21 January 2018

1 reference

p53 as a target in myeloproliferative neoplasms

21 January 2018

1 reference

Bone marrow microenvironment in multiple myeloma progression.

21 January 2018

1 reference

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

21 January 2018

1 reference

MicroRNAs: critical regulators of development, cellular physiology and malignancy

21 January 2018

1 reference

A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes

21 January 2018

1 reference

Surveyor nuclease-based detection of p53 gene mutations in haematological malignancy

21 January 2018

1 reference

The genetic architecture of multiple myeloma.

21 January 2018

1 reference

New strategies in the treatment of multiple myeloma

21 January 2018

1 reference

Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression

21 January 2018

1 reference

Proteotoxic stress targeted therapy (PSTT): induction of protein misfolding enhances the antitumor effect of the proteasome inhibitor bortezomib

21 January 2018

1 reference

Future agents and treatment directions in multiple myeloma

21 January 2018

1 reference

Decision making by p53: life, death and cancer

21 January 2018

1 reference

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

21 January 2018

1 reference

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

21 January 2018

1 reference

Different methylation and microRNA expression pattern in male and female familial breast cancer

21 January 2018

1 reference

Biogenesis, evolution and functional targets of microRNA-125a.

21 January 2018

1 reference

Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen

21 January 2018

1 reference

MicroRNA profiling: approaches and considerations

21 January 2018

1 reference

Tiny actors, great roles: microRNAs in p53's service.

21 January 2018

1 reference

Identification of mammalian microRNA host genes and transcription units

21 January 2018

1 reference

From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario.

21 January 2018

1 reference

Immunologic microenvironment and personalized treatment in multiple myeloma.

21 January 2018

1 reference

Targeting p53 by small molecules in hematological malignancies

21 January 2018

1 reference

Proteotoxic stress targeted therapy (PSTT).

21 January 2018

1 reference

Promises and challenges of MicroRNA-based treatment of multiple myeloma

21 January 2018

1 reference

Bruton's tyrosine kinase: oncotarget in myeloma

21 January 2018

1 reference

Editorial: New approaches in the treatment of multiple myeloma: from target-based agents to the new era of microRNAs (dedicated to the memory of Prof. Salvatore Venuta).

21 January 2018

1 reference

A SCID-hu in vivo model of human Waldenström macroglobulinemia

21 January 2018

1 reference

Genetics and molecular profiling of multiple myeloma: novel tools for clinical management?

21 January 2018

1 reference

Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo

21 January 2018

1 reference

Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma

21 January 2018

1 reference

MicroRNA-mediated feedback and feedforward loops are recurrent network motifs in mammals

21 January 2018

1 reference

A positive role of microRNA-15b on regulation of osteoblast differentiation

21 January 2018

1 reference

21 January 2018

Surfing the p53 network

1 reference

p53 tumor-suppressor gene: Clues to molecular carcinogenesis

21 January 2018

1 reference

MicroRNAs in embryonic stem cells

21 January 2018

1 reference

Methylation of human microRNA genes in normal and neoplastic cells.

21 January 2018

1 reference

Improved risk stratification in myeloma using a microRNA-based classifier.

21 January 2018

1 reference

MicroRNAs and their regulatory roles in animals and plants

21 January 2018

1 reference

MicroRNA 125a and its regulation of the p53 tumor suppressor gene

21 January 2018

1 reference

High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.24669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24819167%20AND%20SRC:MED&resulttype=core&format=json